NCT01931033View on ClinicalTrials.gov

An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 22, 2016

Study Completion Date

February 22, 2016

Conditions
Autism Spectrum DisordersPervasive Developmental DisordersASDPDD
Interventions
DRUG

Intranasal Oxytocin

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01931033 - An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders | Biotech Hunter | Biotech Hunter